Etorphine

Brand names: Captivon 98 · Active ingredient: Etorphine Hydrochloride

In short: CAPTIVON 98 is indicated for immobilisation and anaesthesia of zoo animals, captive wildlife, and free-ranging wildlife species not intended for use as food.

LabelClovis-Davis Pharmaceuticals LLC
Label updatedMay 20, 2026

What is Etorphine used for?

CAPTIVON 98 is indicated for immobilisation and anaesthesia of zoo animals, captive wildlife, and free-ranging wildlife species not intended for use as food.

Etorphine dosage

CAPTIVON 98 (etorphine hydrochloride) dosing is dependent on species, body mass and the condition of the wildlife animal being treated, and doses should be adjusted accordingly. Administration by intravenous or intramuscular injection is recommended. Refer to the table for CAPTIVON 98 dosing.

Warnings & precautions

Do not take this medicine if: Do not use CAPTIVON 98 in domestic animals and wild felids.Do not use carcasses of animals treated with etorphine for human consumption.

CAPTIVON 98 residue studies have not been conducted in wildlife animals and consequently, human and predator consumption of carcasses from animals treated with CAPTIVON 98 is not advisable.

Accidental exposure to CAPTIVON 98 could have serious effects on humans due to the high concentration of the medicine.• The lethal CAPTIVON 98 dose in humans is estimated to be between 30-120 μg.

The following precautions should be taken by veterinarians when using CAPTIVON 98:

• Do not work with CAPTIVON 98 unaccompanied.• Ensure that the antidote (naloxone), and a needle and syringe for administration of the antidote are readily available.• An assistant capable of administering the antidote to humans should always be present and should be fully briefed on the procedure to follow in the event of accidental exposure to CAPTIVON 98.• Wear gloves when handling CAPTIVON 98.• Eye protection should be utilised if there is a risk of CAPTIVON 98 splashing into the eyes.• Ensure water or an appropriate irrigation solution is available to treat accidental exposure of the skin or eyes.• CAPTIVON 98 should not be used in blowpipes or similar devices where the medicine solution is pressurised.• Accidental jabbing with a needle containing CAPTIVON 98 could have serious effects. Once the required dose of CAPTIVON 98 has been withdrawn from the vial, the needle should be immediately discarded into a closed container or sharps bin.

Etorphine side effects

The most serious adverse effect following CAPTIVON 98 administration is respiratory depression, usually observed within the first five minutes after administration. In cases of severe respiratory depression, CAPTIVON 98 should be reversed as soon as possible, and animals should not remain immobilised for longer than necessary to avoid complications.

The use of CAPTIVON 98 in elderly, diseased, emaciated and highly stressed animals carries a greater degree of risk and precautionary measures should be taken, including maintenance of airways and prevention of hyperthermia.

Equids and rhino:

• CAPTIVON 98 may result in a dramatic rise in blood pressure, tachycardia, hyperpyrexia and pronounced muscle tremors.• Administration in rhino may lead to hypoventilation, hypoxaemia and metabolic acidosis.

Ungulates

• Significant hypertension due to an increase in total peripheral resistance, and moderate to severe bradycardia has been reported in ungulate species.• Excitement, increased muscle tone and resulting hyperthermia is particularly common in ungulates.• Passive regurgitation of rumen contents is common, and ruminants should be kept in sternal recumbency with heads lifted and tilted downwards to prevent aspiration pneumonia.• Under-dosing may cause hyper-excitability, hyperventilation and severe alkalosis.

The safety of CAPTIVON 98 in pregnant and lactating wildlife animals has not been established. …

About this medicine

CII

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

VETERINARY MEDICINE

SCHEDULING STATUS

S6

How it works: Etorphine is a highly potent, semi-synthetic opioid derivative of oripavine and is classified as a pure agonist. It acts stereospecifically on μ-, δ- and к-opioid receptors, inducing catatonia associated with analgesia at low doses.

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID de5131dc-6c09-4ef4-b62d-ce66c0b5c52f. Read the full official label on DailyMed.